<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39334929</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>17</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>Potential Plasma Proteins (LGALS9, LAMP3, PRSS8 and AGRN) as Predictors of Hospitalisation Risk in COVID-19 Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1163</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom14091163</ELocationID><Abstract><AbstractText><i>Background:</i> The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has posed unprecedented challenges to healthcare systems worldwide. Here, we have identified proteomic and genetic signatures for improved prognosis which is vital for COVID-19 research. <i>Methods:</i> We investigated the proteomic and genomic profile of COVID-19-positive patients (n = 400 for proteomics, n = 483 for genomics), focusing on differential regulation between hospitalised and non-hospitalised COVID-19 patients. Signatures had their predictive capabilities tested using independent machine learning models such as Support Vector Machine (SVM), Random Forest (RF) and Logistic Regression (LR). <i>Results:</i> This study has identified 224 differentially expressed proteins involved in various inflammatory and immunological pathways in hospitalised COVID-19 patients compared to non-hospitalised COVID-19 patients. LGALS9 (<i>p</i>-value &lt; 0.001), LAMP3 (<i>p</i>-value &lt; 0.001), PRSS8 (<i>p</i>-value &lt; 0.001) and AGRN (<i>p</i>-value &lt; 0.001) were identified as the most statistically significant proteins. Several hundred rsIDs were queried across the top 10 significant signatures, identifying three significant SNPs on the <i>FSTL3</i> gene showing a correlation with hospitalisation status. <i>Conclusions:</i> Our study has not only identified key signatures of COVID-19 patients with worsened health but has also demonstrated their predictive capabilities as potential biomarkers, which suggests a staple role in the worsened health effects caused by COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McLarnon</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3175-9779</Identifier><AffiliationInfo><Affiliation>Personalised Medicine Centre, C-TRIC Building, Altnagelvin Area Hospital, School of Medicine, Ulster University, Glenshane Road, Derry-Londonderry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDaid</LastName><ForeName>Darren</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Personalised Medicine Centre, C-TRIC Building, Altnagelvin Area Hospital, School of Medicine, Ulster University, Glenshane Road, Derry-Londonderry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Seodhna M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0002-5738-1129</Identifier><AffiliationInfo><Affiliation>Personalised Medicine Centre, C-TRIC Building, Altnagelvin Area Hospital, School of Medicine, Ulster University, Glenshane Road, Derry-Londonderry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Eamonn</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-0432-016X</Identifier><AffiliationInfo><Affiliation>Personalised Medicine Centre, C-TRIC Building, Altnagelvin Area Hospital, School of Medicine, Ulster University, Glenshane Road, Derry-Londonderry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLaughlin</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Personalised Medicine Centre, C-TRIC Building, Altnagelvin Area Hospital, School of Medicine, Ulster University, Glenshane Road, Derry-Londonderry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGilligan</LastName><ForeName>Victoria E</ForeName><Initials>VE</Initials><AffiliationInfo><Affiliation>Personalised Medicine Centre, C-TRIC Building, Altnagelvin Area Hospital, School of Medicine, Ulster University, Glenshane Road, Derry-Londonderry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watterson</LastName><ForeName>Steven</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2750-6410</Identifier><AffiliationInfo><Affiliation>Personalised Medicine Centre, C-TRIC Building, Altnagelvin Area Hospital, School of Medicine, Ulster University, Glenshane Road, Derry-Londonderry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shukla</LastName><ForeName>Priyank</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4985-9305</Identifier><AffiliationInfo><Affiliation>Personalised Medicine Centre, C-TRIC Building, Altnagelvin Area Hospital, School of Medicine, Ulster University, Glenshane Road, Derry-Londonderry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shu-Dong</ForeName><Initials>SD</Initials><Identifier Source="ORCID">0000-0002-7721-0167</Identifier><AffiliationInfo><Affiliation>Personalised Medicine Centre, C-TRIC Building, Altnagelvin Area Hospital, School of Medicine, Ulster University, Glenshane Road, Derry-Londonderry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bucholc</LastName><ForeName>Magda</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8417-1602</Identifier><AffiliationInfo><Affiliation>School of Computing, Engineering &amp; Intelligent Systems, Ulster University, Derry BT48 7JL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>English</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1232-5585</Identifier><AffiliationInfo><Affiliation>Personalised Medicine Centre, C-TRIC Building, Altnagelvin Area Hospital, School of Medicine, Ulster University, Glenshane Road, Derry-Londonderry BT47 6SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Health and Life Sciences, Teesside University, Campus Heart, Middlesbrough TS1 3BX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peace</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9556-7509</Identifier><AffiliationInfo><Affiliation>Personalised Medicine Centre, C-TRIC Building, Altnagelvin Area Hospital, School of Medicine, Ulster University, Glenshane Road, Derry-Londonderry BT47 6SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Altnagelvin Area Hospital, Western Health and Social Care Trust, Derry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Kane</LastName><ForeName>Maurice</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Personalised Medicine Centre, C-TRIC Building, Altnagelvin Area Hospital, School of Medicine, Ulster University, Glenshane Road, Derry-Londonderry BT47 6SB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Chemistry Laboratory, Altnagelvin Hospital, Derry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1462-815X</Identifier><AffiliationInfo><Affiliation>Altnagelvin Area Hospital, Western Health and Social Care Trust, Derry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhavsar</LastName><ForeName>Manav</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Altnagelvin Area Hospital, Western Health and Social Care Trust, Derry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Elaine K</ForeName><Initials>EK</Initials><Identifier Source="ORCID">0000-0003-0170-6809</Identifier><AffiliationInfo><Affiliation>Personalised Medicine Centre, C-TRIC Building, Altnagelvin Area Hospital, School of Medicine, Ulster University, Glenshane Road, Derry-Londonderry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibson</LastName><ForeName>David S</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0003-3547-5551</Identifier><AffiliationInfo><Affiliation>Personalised Medicine Centre, C-TRIC Building, Altnagelvin Area Hospital, School of Medicine, Ulster University, Glenshane Road, Derry-Londonderry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>Colum P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Biomedical Sciences Research Institute, University of Ulster, Coleraine BT52 1SA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bjourson</LastName><ForeName>Anthony J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0002-1105-7147</Identifier><AffiliationInfo><Affiliation>Personalised Medicine Centre, C-TRIC Building, Altnagelvin Area Hospital, School of Medicine, Ulster University, Glenshane Road, Derry-Londonderry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rai</LastName><ForeName>Taranjit Singh</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Personalised Medicine Centre, C-TRIC Building, Altnagelvin Area Hospital, School of Medicine, Ulster University, Glenshane Road, Derry-Londonderry BT47 6SB, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>COM/5618/20</GrantID><Agency>HSC R&amp;D Division, Public Health Agency</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001798">Blood Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037161">Galectins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051907">Lysosomal Membrane Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001798" MajorTopicYN="Y">Blood Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037161" MajorTopicYN="N">Galectins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051907" MajorTopicYN="N">Lysosomal Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AGRN</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">LAMP3</Keyword><Keyword MajorTopicYN="N">LGALS9</Keyword><Keyword MajorTopicYN="N">Logistic Regression</Keyword><Keyword MajorTopicYN="N">PRSS8</Keyword><Keyword MajorTopicYN="N">Random Forest</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Support Vector Machine</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39334929</ArticleId><ArticleId IdType="pmc">PMC11429560</ArticleId><ArticleId IdType="doi">10.3390/biom14091163</ArticleId><ArticleId IdType="pii">biom14091163</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . WHO Coronavirus (COVID-19) Dashboard. World Health Organization; Geneva, Switzerland: 2023.</Citation></Reference><Reference><Citation>van Eijk L.E., Binkhorst M., Bourgonje A.R., Offringa A.K., Mulder D.J., Bos E.M., Kolundzic N., E Abdulle A., van der Voort P.H., Rikkert M.G.O., et al. COVID-19: Immunopathology, pathophysiological mechanisms, and treatment options. J. Pathol. 2021;254:307–331. doi: 10.1002/path.5642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5642</ArticleId><ArticleId IdType="pmc">PMC8013908</ArticleId><ArticleId IdType="pubmed">33586189</ArticleId></ArticleIdList></Reference><Reference><Citation>Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783–801. doi: 10.1016/j.cell.2006.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.02.015</ArticleId><ArticleId IdType="pubmed">16497588</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y., Liu J., Zhang D., Xu Z., Ji J., Wen C. Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies. Front. Immunol. 2020;11:1708. doi: 10.3389/fimmu.2020.01708.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01708</ArticleId><ArticleId IdType="pmc">PMC7365923</ArticleId><ArticleId IdType="pubmed">32754163</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y.-R., Cao Q.-D., Hong Z.-S., Tan Y.-Y., Chen S.-D., Jin H.-J., Tan K.-S., Wang D.-Y., Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak—An update on the status. Mil. Med. Res. 2020;7:11. doi: 10.1186/s40779-020-00240-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40779-020-00240-0</ArticleId><ArticleId IdType="pmc">PMC7068984</ArticleId><ArticleId IdType="pubmed">32169119</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaney T., Neves A.L., Alboksmaty A., Ashrafian H., Flott K., Fowler A., Benger J.R., Aylin P., Elkin S., Darzi A., et al. Trends and associated factors for Covid-19 hospitalisation and fatality risk in 2.3 million adults in England. Nat. Commun. 2022;13:2356. doi: 10.1038/s41467-022-29880-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29880-7</ArticleId><ArticleId IdType="pmc">PMC9054846</ArticleId><ArticleId IdType="pubmed">35487905</ArticleId></ArticleIdList></Reference><Reference><Citation>Khedar R.S., Gupta R., Sharma K., Mittal K., Ambaliya H.C., Gupta J.B., Singh S., Sharma S., Singh Y., Mathur A. Biomarkers and outcomes in hospitalised patients with COVID-19: A prospective registry. BMJ Open. 2022;12:e067430. doi: 10.1136/bmjopen-2022-067430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-067430</ArticleId><ArticleId IdType="pmc">PMC9755908</ArticleId><ArticleId IdType="pubmed">36521904</ArticleId></ArticleIdList></Reference><Reference><Citation>English A., McDaid D., Lynch S.M., McLaughlin J., Cooper E., Wingfield B., Kelly M., Bhavsar M., McGilligan V., Irwin R.E., et al. Genomic, Proteomic, and Phenotypic Biomarkers of COVID-19 Severity: Protocol for a Retrospective Observational Study. JMIR Res. Protoc. 2024;13:e50733. doi: 10.2196/50733.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/50733</ArticleId><ArticleId IdType="pmc">PMC10868637</ArticleId><ArticleId IdType="pubmed">38354037</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazici D., Cagan E., Tan G., Li M., Do E., Kucukkase O.C., Simsek A., Kizmaz M.A., Bozkurt T., Aydin T., et al. Disrupted epithelial permeability as a predictor of severe COVID-19 development. Allergy. 2023;78:2644–2658. doi: 10.1111/all.15800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15800</ArticleId><ArticleId IdType="pubmed">37422701</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Y., Ma X., Ma Y., Du Y., Feng J. A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9) Genes Dis. 2023;10:2366–2382. doi: 10.1016/j.gendis.2022.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gendis.2022.05.020</ArticleId><ArticleId IdType="pmc">PMC10404877</ArticleId><ArticleId IdType="pubmed">37554219</ArticleId></ArticleIdList></Reference><Reference><Citation>Teft W.A., Kirchhof M.G., Madrenas J. A Molecular Perspective Of CTLA-4 Function. Annu. Rev. Immunol. 2006;24:65–97. doi: 10.1146/annurev.immunol.24.021605.090535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.24.021605.090535</ArticleId><ArticleId IdType="pubmed">16551244</ArticleId></ArticleIdList></Reference><Reference><Citation>de Saint-Vis B., Vincent J., Vandenabeele S., Vanbervliet B., Pin J.-J., Aït-Yahia S., Patel S., Mattei M.-G., Banchereau J., Zurawski S., et al. A Novel Lysosome-Associated Membrane Glycoprotein, DC-LAMP, Induced upon DC Maturation, Is Transiently Expressed in MHC Class II Compartment. Immunity. 1998;9:325–336. doi: 10.1016/s1074-7613(00)80615-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1074-7613(00)80615-9</ArticleId><ArticleId IdType="pubmed">9768752</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Liang J., Lu T., Li M., Shan G., Bi G., Zhao M., Jin X., Wang Q., Chen Z., et al. AGRN promotes lung adenocarcinoma progression by activating Notch signaling pathway and acts as a therapeutic target. Pharmacol. Res. 2023;194:106819. doi: 10.1016/j.phrs.2023.106819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2023.106819</ArticleId><ArticleId IdType="pubmed">37321467</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaric L., Gisby J.S., Papadaki A., Muckian M.D., Macdonald-Dunlop E., Zhao J.H., Peters J.E. Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19. MedRxiv. 2021 doi: 10.1101/2021.04.01.21254789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.01.21254789</ArticleId></ArticleIdList></Reference><Reference><Citation>Groffen A.J.A., Buskens C.A.F., van Kuppevelt T.H., Veerkamp J.H., Monnens L.A.H., Heuvel L.P.W.J.v.D. Primary structure and high expression of human agrin in basement membranes of adult lung and kidney. Eur. J. Biochem. 1998;254:123–128. doi: 10.1046/j.1432-1327.1998.2540123.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1432-1327.1998.2540123.x</ArticleId><ArticleId IdType="pubmed">9652404</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer A., Pachl E., Hellmuth J.C., Kneidinger N., Heydarian M., Frankenberger M., Stubbe H.C., Ryffel B., Petrera A., Hauck S.M., et al. Proteomics reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients. Biochim. et Biophys. Acta (BBA)–Mol. Basis Dis. 2023;1869:166592. doi: 10.1016/j.bbadis.2022.166592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2022.166592</ArticleId><ArticleId IdType="pmc">PMC9622026</ArticleId><ArticleId IdType="pubmed">36328146</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozorgmehr N., Mashhouri S., Rosero E.P., Xu L., Shahbaz S., Sligl W., Osman M., Kutsogiannis D.J., MacIntyre E., O’neil C.R., et al. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection. mBio. 2021;12:e00384-21. doi: 10.1128/mbio.00384-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00384-21</ArticleId><ArticleId IdType="pmc">PMC8262904</ArticleId><ArticleId IdType="pubmed">33947753</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Kirsch R., Koutrouli M., Nastou K., Mehryary F., Hachilif R., Gable A.L., Fang T., Doncheva N.T., Pyysalo S., et al. The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638–D646. doi: 10.1093/nar/gkac1000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac1000</ArticleId><ArticleId IdType="pmc">PMC9825434</ArticleId><ArticleId IdType="pubmed">36370105</ArticleId></ArticleIdList></Reference><Reference><Citation>Funaro A., Spagnoli G.C., Momo M., Knapp W., Malavasi F. Stimulation of T cells via CD44 requires leukocyte-function-associated antigen interactions and interleukin-2 production. Hum. Immunol. 1994;40:267–278. doi: 10.1016/0198-8859(94)90026-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0198-8859(94)90026-4</ArticleId><ArticleId IdType="pubmed">7528188</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Liu S., Liu J., Zhang Z., Wan X., Huang B., Chen Y., Zhang Y. COVID-19: Immunopathogenesis and Immunotherapeutics. Signal Transduct. Target. Ther. 2020;5:128. doi: 10.1038/s41392-020-00243-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00243-2</ArticleId><ArticleId IdType="pmc">PMC7381863</ArticleId><ArticleId IdType="pubmed">32712629</ArticleId></ArticleIdList></Reference><Reference><Citation>Roh J.D., Kitchen R.R., Guseh J.S., McNeill J.N., Aid M., Martinot A.J., Yu A., Platt C., Rhee J., Weber B., et al. Plasma Proteomics of COVID-19–Associated Cardiovascular Complications. JACC Basic Transl. Sci. 2022;7:425–441. doi: 10.1016/j.jacbts.2022.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2022.01.013</ArticleId><ArticleId IdType="pmc">PMC9067411</ArticleId><ArticleId IdType="pubmed">35530264</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>